The effect of nitroglycerin upon pulmonary and left atrial pressures in patients with mitral stenosis

Donald A. Rothbaum, James C. Dillon, Harvey Feigenbaum

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In all nine patients studied with mitral stenosis and no evidence of left ventricular failure, nitroglycerin caused a decrease in pulmonary arterial, left atrial, and left ventricular pressures and pulmonary vascular resistance. The decrease in left atrial pressure was attributable to the combination of a reduction in left ventricular filling pressure and a reduction in mitral valve gradient. While there was no significant mean change in heart rate, cardiac index, or mitral valve flow, there was a significant correlation between a decrease in each of these determinants of mitral valve gradient and the observed decline in left atrial pressure in individual patients. However, even those patients who had an increase in heart rate or cardiac output, either of which normally aggravates pulmonary congestion in mitral stenosis, 11, 22 had a decrease in their pulmonary and left atrial pressures in response to TNG. It is likely that nitroglycerin reduced pulmonary and left atrial pressures by either (1) systemic venous dilatation, causing a reduction in right heart filling and pulmonary blood volume, or (2) pulmonary arteriolar and venous dilatation, causing a decrease in pulmonary vascular resistance and an increase in pulmonary vascular compliance. Because of the efficacy of TNG in lowering pulmonary and left atrial pressures in this study, TNG may prove useful in the clinical management of symptomatic pulmonary congestion in mitral stenosis.

Original languageEnglish (US)
Pages (from-to)156-162
Number of pages7
JournalAmerican Heart Journal
Volume91
Issue number2
DOIs
StatePublished - Feb 1976

Fingerprint

Atrial Pressure
Mitral Valve Stenosis
Nitroglycerin
Lung
Mitral Valve
Ventricular Pressure
Vascular Resistance
Dilatation
Heart Rate
Lung Compliance
Heart Valves
Blood Volume
Cardiac Output
Blood Vessels

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The effect of nitroglycerin upon pulmonary and left atrial pressures in patients with mitral stenosis. / Rothbaum, Donald A.; Dillon, James C.; Feigenbaum, Harvey.

In: American Heart Journal, Vol. 91, No. 2, 02.1976, p. 156-162.

Research output: Contribution to journalArticle

@article{1f1f43874e054b0aaf9ab875508cd1b6,
title = "The effect of nitroglycerin upon pulmonary and left atrial pressures in patients with mitral stenosis",
abstract = "In all nine patients studied with mitral stenosis and no evidence of left ventricular failure, nitroglycerin caused a decrease in pulmonary arterial, left atrial, and left ventricular pressures and pulmonary vascular resistance. The decrease in left atrial pressure was attributable to the combination of a reduction in left ventricular filling pressure and a reduction in mitral valve gradient. While there was no significant mean change in heart rate, cardiac index, or mitral valve flow, there was a significant correlation between a decrease in each of these determinants of mitral valve gradient and the observed decline in left atrial pressure in individual patients. However, even those patients who had an increase in heart rate or cardiac output, either of which normally aggravates pulmonary congestion in mitral stenosis, 11, 22 had a decrease in their pulmonary and left atrial pressures in response to TNG. It is likely that nitroglycerin reduced pulmonary and left atrial pressures by either (1) systemic venous dilatation, causing a reduction in right heart filling and pulmonary blood volume, or (2) pulmonary arteriolar and venous dilatation, causing a decrease in pulmonary vascular resistance and an increase in pulmonary vascular compliance. Because of the efficacy of TNG in lowering pulmonary and left atrial pressures in this study, TNG may prove useful in the clinical management of symptomatic pulmonary congestion in mitral stenosis.",
author = "Rothbaum, {Donald A.} and Dillon, {James C.} and Harvey Feigenbaum",
year = "1976",
month = "2",
doi = "10.1016/S0002-8703(76)80569-8",
language = "English (US)",
volume = "91",
pages = "156--162",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - The effect of nitroglycerin upon pulmonary and left atrial pressures in patients with mitral stenosis

AU - Rothbaum, Donald A.

AU - Dillon, James C.

AU - Feigenbaum, Harvey

PY - 1976/2

Y1 - 1976/2

N2 - In all nine patients studied with mitral stenosis and no evidence of left ventricular failure, nitroglycerin caused a decrease in pulmonary arterial, left atrial, and left ventricular pressures and pulmonary vascular resistance. The decrease in left atrial pressure was attributable to the combination of a reduction in left ventricular filling pressure and a reduction in mitral valve gradient. While there was no significant mean change in heart rate, cardiac index, or mitral valve flow, there was a significant correlation between a decrease in each of these determinants of mitral valve gradient and the observed decline in left atrial pressure in individual patients. However, even those patients who had an increase in heart rate or cardiac output, either of which normally aggravates pulmonary congestion in mitral stenosis, 11, 22 had a decrease in their pulmonary and left atrial pressures in response to TNG. It is likely that nitroglycerin reduced pulmonary and left atrial pressures by either (1) systemic venous dilatation, causing a reduction in right heart filling and pulmonary blood volume, or (2) pulmonary arteriolar and venous dilatation, causing a decrease in pulmonary vascular resistance and an increase in pulmonary vascular compliance. Because of the efficacy of TNG in lowering pulmonary and left atrial pressures in this study, TNG may prove useful in the clinical management of symptomatic pulmonary congestion in mitral stenosis.

AB - In all nine patients studied with mitral stenosis and no evidence of left ventricular failure, nitroglycerin caused a decrease in pulmonary arterial, left atrial, and left ventricular pressures and pulmonary vascular resistance. The decrease in left atrial pressure was attributable to the combination of a reduction in left ventricular filling pressure and a reduction in mitral valve gradient. While there was no significant mean change in heart rate, cardiac index, or mitral valve flow, there was a significant correlation between a decrease in each of these determinants of mitral valve gradient and the observed decline in left atrial pressure in individual patients. However, even those patients who had an increase in heart rate or cardiac output, either of which normally aggravates pulmonary congestion in mitral stenosis, 11, 22 had a decrease in their pulmonary and left atrial pressures in response to TNG. It is likely that nitroglycerin reduced pulmonary and left atrial pressures by either (1) systemic venous dilatation, causing a reduction in right heart filling and pulmonary blood volume, or (2) pulmonary arteriolar and venous dilatation, causing a decrease in pulmonary vascular resistance and an increase in pulmonary vascular compliance. Because of the efficacy of TNG in lowering pulmonary and left atrial pressures in this study, TNG may prove useful in the clinical management of symptomatic pulmonary congestion in mitral stenosis.

UR - http://www.scopus.com/inward/record.url?scp=0017253293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017253293&partnerID=8YFLogxK

U2 - 10.1016/S0002-8703(76)80569-8

DO - 10.1016/S0002-8703(76)80569-8

M3 - Article

C2 - 813508

AN - SCOPUS:0017253293

VL - 91

SP - 156

EP - 162

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 2

ER -